PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Price, Quote, News and Overview
NYSE:PBH - New York Stock Exchange, Inc. - US74112D1019 - Common Stock - Currency: USD
PBH Quote, Performance and Key Statistics
85.01
+0.59 (+0.7%)
The current stock price of PBH is 85.01 USD. In the past month the price increased by 6.89%. In the past year, price increased by 32.89%.
PBH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.98 | 678.00B | ||
| JNJ | JOHNSON & JOHNSON | 15.19 | 367.19B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.48 | 302.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.54 | 222.20B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.87B | ||
| MRK | MERCK & CO. INC. | 9.99 | 195.88B | ||
| PFE | PFIZER INC | 7.18 | 130.67B | ||
| SNY | SANOFI-ADR | 13.71 | 128.55B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.41 | 95.71B | ||
| GSK | GSK PLC-SPON ADR | 7.06 | 78.75B | ||
| ZTS | ZOETIS INC | 26.91 | 72.25B | ||
| HLN | HALEON PLC-ADR | 22.57 | 49.87B |
Related stock screener links
About PBH
Company Profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 570 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Company Info
PRESTIGE CONSUMER HEALTHCARE
660 White Plains Rd.
Tarrytown NEW YORK 10591 US
CEO: Ronald M. Lombardi
Employees: 570
Phone: 19145246800
PRESTIGE CONSUMER HEALTHCARE / PBH FAQ
What is the stock price of PRESTIGE CONSUMER HEALTHCARE today?
The current stock price of PBH is 85.01 USD. The price increased by 0.7% in the last trading session.
What is the ticker symbol for PRESTIGE CONSUMER HEALTHCARE stock?
The exchange symbol of PRESTIGE CONSUMER HEALTHCARE is PBH and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PBH stock listed?
PBH stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PRESTIGE CONSUMER HEALTHCARE stock?
10 analysts have analysed PBH and the average price target is 90.78 USD. This implies a price increase of 6.79% is expected in the next year compared to the current price of 85.01. Check the PRESTIGE CONSUMER HEALTHCARE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PRESTIGE CONSUMER HEALTHCARE worth?
PRESTIGE CONSUMER HEALTHCARE (PBH) has a market capitalization of 4.21B USD. This makes PBH a Mid Cap stock.
How many employees does PRESTIGE CONSUMER HEALTHCARE have?
PRESTIGE CONSUMER HEALTHCARE (PBH) currently has 570 employees.
What are the support and resistance levels for PRESTIGE CONSUMER HEALTHCARE (PBH) stock?
PRESTIGE CONSUMER HEALTHCARE (PBH) has a support level at 84.67 and a resistance level at 89.02. Check the full technical report for a detailed analysis of PBH support and resistance levels.
Is PRESTIGE CONSUMER HEALTHCARE (PBH) expected to grow?
The Revenue of PRESTIGE CONSUMER HEALTHCARE (PBH) is expected to grow by 1.58% in the next year. Check the estimates tab for more information on the PBH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PRESTIGE CONSUMER HEALTHCARE (PBH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PBH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PBH, evaluating the profitability, health, valuation and growth aspects
- PRESTIGE CONSUMER HEALTHCARE (PBH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PRESTIGE CONSUMER HEALTHCARE (PBH) Sales and EPS estimates to see what analysts future expectations are.
- PRESTIGE CONSUMER HEALTHCARE (PBH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PRESTIGE CONSUMER HEALTHCARE (PBH) Insider and Institutional Ownership to learn about the owners and their transactions.
- PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Chart to make your own analysis
- PRESTIGE CONSUMER HEALTHCARE (PBH) Latest news and press-releases to stay up to date.
Does PRESTIGE CONSUMER HEALTHCARE (PBH) stock pay dividends?
PBH does not pay a dividend.
When does PRESTIGE CONSUMER HEALTHCARE (PBH) report earnings?
PRESTIGE CONSUMER HEALTHCARE (PBH) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of PRESTIGE CONSUMER HEALTHCARE (PBH)?
The PE ratio for PRESTIGE CONSUMER HEALTHCARE (PBH) is 18.77. This is based on the reported non-GAAP earnings per share of 4.53 and the current share price of 85.01 USD. Check the full fundamental report for a full analysis of the valuation metrics for PBH.
What is the Short Interest ratio of PRESTIGE CONSUMER HEALTHCARE (PBH) stock?
The outstanding short interest for PRESTIGE CONSUMER HEALTHCARE (PBH) is 3.24% of its float. Check the ownership tab for more information on the PBH short interest.
PBH Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PBH. When comparing the yearly performance of all stocks, PBH is one of the better performing stocks in the market, outperforming 87.72% of all stocks.
PBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PBH. PBH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
PBH Financial Highlights
Over the last trailing twelve months PBH reported a non-GAAP Earnings per Share(EPS) of 4.53. The EPS increased by 8.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.86% | ||
| ROA | 6.31% | ||
| ROE | 11.7% | ||
| Debt/Equity | 0.55 |
PBH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to PBH. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 6.35% and a revenue growth 1.58% for PBH